Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on... (ss otherwise noted Amgen is providing th...)

HOME >> MEDICINE >> TECHNOLOGY

Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss

Date:7/5/2011

ss otherwise noted, Amgen is providing this information as of July 5, 2011 and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement polici
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program

Post Your Comments:

(Date:5/16/2013)... , May 16, 2013 Amgen (NASDAQ: AMGN ... on Tuesday, May 21, 2013, at the Sheraton New York ... beginning at 10:00 a.m. Eastern Daylight Time. Joseph ... Research and Development at Amgen, will present at the conference. ... Events Calendar on Amgen,s website, www.amgen.com , under Investors. ...

(Date:5/16/2013)... May 16, 2013 ULURU Inc. (OTCQB: ULUR) today announced ... 2013 and provided a review of its operating activities. ... confirming the previously communicated outlook for 2013: , Launching ... the network of distribution partners to cover all major markets ... Altrazeal ® to be marketed in approximately 50 markets ...

(Date:5/16/2013)... , May 16, 2013 Actinium ... that develops innovative targeted payload immunotherapeutics for ... official program of TAT: Target Alpha Therapy ... devoted to Actinium Pharmaceuticals, clinical programs. The ... Leukemia with Bismuth-213 and Actinium-225" has been ...

Breaking Medicine Technology:ULURU Inc. Reports First Quarter 2013 Financial Results 2 ULURU Inc. Reports First Quarter 2013 Financial Results 3 ULURU Inc. Reports First Quarter 2013 Financial Results 4 ULURU Inc. Reports First Quarter 2013 Financial Results 5 Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference 2 Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference 3

[0] Amgen To Present At The UBS Global Life Sciences Conference [0] ULURU Inc. Reports First Quarter 2013 Financial Results [0] Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference

... Oramed Pharmaceuticals, Inc.,(OTC: ORMP) ( http://www.oramed.com ), a ... clinical trials will commence this week on 30 ... evaluate the safety,tolerability and efficacy of its oral ... (CRO) located in Johannesburg,South Africa, will oversee the ...

... of H1N1 Flu (Swine Flu) cases grows in the ... Association wishes to ease public concern by offering proven ... respiratory illnesses ranging from the common cold to H1N1 ... America respond to lung disease for more than 100 ...

Cached Medicine Technology:Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule 2 American Lung Association Offers Simple Tips to Protect Public Health and Minimize H1N1 Flu (Swine Flu) and Seasonal Flu Transmission 2 American Lung Association Offers Simple Tips to Protect Public Health and Minimize H1N1 Flu (Swine Flu) and Seasonal Flu Transmission 3

Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule American Lung Association Offers Simple Tips to Protect Public Health and Minimize H1N1 Flu (Swine Flu) and Seasonal Flu Transmission

(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic Devices ... Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user ... studies the major market drivers, restraints, and opportunities in ... , Browse , 147 market ... , 318 pagesand in-depth TOC of ...

(Date:5/18/2013)... The California College of Ayurveda Spa ... Ayurvedic Spa , the client receives stress relief ... and lifestyle recommendations and stress management techniques by a ... the traditional healthcare system of India. It is based ... the basis for all optimum health. Ayurveda believes that ...

(Date:5/18/2013)... Spectrum Surgical Instruments will attend ... in Austin, TX where thousands of GI nursing ... opportunities. , Spectrum Surgical/STERIS will feature its ... capabilities and certified pre-owned equipment. Attendees will ... proper instrument care of flexible endoscopes. , ...

(Date:5/18/2013)... May 18, 2013 Kimono condoms ... America’s favorite condom store recently announced. Condomania recently ... store's large selection of condoms from all over the ... it easy to try different condom styles from one ... Featuring Kimono’s classic comfortable shape and secure, the new ...

(Date:5/18/2013)... 18, 2013 Three new locations will ... and wellness centers and one therapeutic dispensary. Patient Appreciation ... the weekend of May 25th – May 27th, particularly ... Day. All events will take place from ... , Elements Therapeutic Dispensary , 10580 S. State Route ...

Breaking Medicine News(10 mins):Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2 Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3 Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2 Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2 Health News:Kimono Condoms Assorted Sampler Packs Now Available at Condomania 2 Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 2 Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 3 Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 4

[0] Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets [0] Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center [0] Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX [0] Kimono Condoms Assorted Sampler Packs Now Available at Condomania [0] Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary

... You could say two is a small number. , But ... professor of exercise and sports science in the College of ... Chapel Hill. , The figure represents the number of reported ... players in 2007. To Mueller, it also represents two young ...

... lead to new treatments, experts say , , WEDNESDAY, ... approaches to treating Alzheimer,s disease could one day lead ... , A trio of studies that were expected to ... Conference on Alzheimer,s Disease in Chicago noted progress made ...

... cocaine show a persistent cellular memory in the brain,s ... the drug, while their involuntary counterparts had no such ... the University of California, San Francisco. , The researchers ... not enough to cause long-lasting cellular memories in the ...

... 30th,Representative Jose Serrano (D-NY) introduced the Community AIDS ... will remove all legal,barriers to States and local ... prevention of diseases directly on syringe exchange.,Syringe exchanges ... intravenous,drug users obtain clean syringes in order to ...

... Toronto Stock Exchange Symbol: CYT, MONTREAL, ... the global leader in cryotherapy products to treat ... CEO of,CryoCath, will present a corporate update at ... will take place Wednesday, August,6th at 8:30 a.m. ...

... gear up to travel to China for the 2008 ... illnesses and dog bites, according to report by an ... Centers for Disease Control and Prevention (CDC) and around ... lead to human rabies. The report finds that respiratory ...

UNC report: Heat-related deaths in high school football players dip, but all are preventable Advances Made Against Alzheimer's Disease Cocaine addiction linked to voluntary drug use and cellular memory, UCSF study shows AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs CryoCath to Present at BMO Healthcare Conference Respiratory illnesses and dog bites a concern for travelers to China for 2008 Olympics

This is a 2.5x focusing Galilean telescope with a range from 70cm to infinity. Ideal for use at sporting events, as well as for a wide range of hobbies....

... Wide-Vu magnifier is our most ... reading. It offers a ... the LVA21 and hence a ... Wide-Vu can be mounted to ...

This 6x or 8x aspheric magnifier is fitted with a distance piece and is particularly useful for patients with tremor or focusing difficulties. The magnifier can be either spectacle mounted or hand h...

This full segment bifocal can be screwed into a hole in a corrective or plano lens, or mounted directly on top of a prescription lens....

Medicine Products:

Sports Mag Wide-Vu Mag Stedi-Fit Mag Bifocal Mag